Research Field
The core hallmarks of cancer include metabolic reprogramming and avoidance of cell death, which contribute to significant resistance to apoptosis-induction therapy in many tumors. Thus, the study of novel forms of cell death has been a promising direction in tumor treatment. We combine approaches such as molecular cell biology, biochemistry, metabolomics, proteomics, high-throughput screening, and bioinformatics to investigate the regulatory networks of regulated cell death processes in tumor cells. We aim to translate our basic research findings into the development of new anti-tumor drugs and potentially therapeutic approaches.
Working experience
2023～present Institute of Translational Medicine, University School of Medicine, Zhejiang University/The Second Affiliated Hospital, Zhejiang University, Principle Investigator/ Doctoral supervisor
2022～2023 MD Anderson Cancer Center, Instructor
2017～2022 MD Anderson Cancer Center, Postdoctoral Fellow
Education Background
2012～2017 Ph.D. (Master-Ph.D. continuous study), East China Normal University, Shanghai, China
2008～2012 Bachelor, Jiangxi Normal University, Jiangxi, China
Honors
2021 Jeffrey Lee Cousins Fellowship in Lung Cancer Research, MD Anderson Cancer Center
2020 effrey Lee Cousins Fellowship in Lung Cancer Research, MD Anderson Cancer Center
2017 Wisdom Scholarship, East China Normal University
2012 Excellent Graduate Award, Jiangxi Normal University
2011 First-Class Scholarship, Jiangxi Normal University
2010 First-Class Scholarship, Jiangxi Normal University
2009 Second-Class Scholarship, Jiangxi Normal University
